N-[4-[1-(3,4-dimethoxybenzoyl)piperidin-4-yl]phenyl]-7-fluoro-2H-indazole-3-carboxamide
C28H27FN4O4 — CID 171685415
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[4-[1-(3,4-dimethoxybenzoyl)piperidin-4-yl]phenyl]-7-fluoro-2H-indazole-3-carboxamide
N-[4-[1-(3,4-dimethoxybenzoyl)piperidin-4-yl]phenyl]-7-fluoro-2H-indazole-3-carboxamide (PubChem CID 171685415) has the molecular formula C28H27FN4O4 and a molecular weight of 502.55 g/mol. Its IUPAC name is N-[4-[1-(3,4-dimethoxybenzoyl)piperidin-4-yl]phenyl]-7-fluoro-2H-indazole-3-carboxamide.
Molecular Properties
| Compound Name | N-[4-[1-(3,4-dimethoxybenzoyl)piperidin-4-yl]phenyl]-7-fluoro-2H-indazole-3-carboxamide |
|---|---|
| PubChem CID | 171685415 |
| Molecular Formula | C28H27FN4O4 |
| Molecular Weight | 502.55 g/mol |
| Exact Mass | 502.20 |
| IUPAC Name | N-[4-[1-(3,4-dimethoxybenzoyl)piperidin-4-yl]phenyl]-7-fluoro-2H-indazole-3-carboxamide |
| SMILES | COc1ccc(C(=O)N2CCC(c3ccc(NC(=O)c4[nH]nc5c(F)cccc45)cc3)CC2)cc1OC |
| InChI | InChI=1S/C28H27FN4O4/c1-36-23-11-8-19(16-24(23)37-2)28(35)33-14-12-18(13-15-33)17-6-9-20(10-7-17)30-27(34)26-21-4-3-5-22(29)25(21)31-32-26/h3-11,16,18H,12-15H2,1-2H3,(H,30,34)(H,31,32) |
| InChIKey | MMCCMNYWVBIPPK-UHFFFAOYSA-N |
| XLogP | 4.99 |
| TPSA | 96.55 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 502.55 |
| LogP ≤ 5 | 4.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171685415 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.